Page 16 - Amrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Amrx Today - Breaking & Trending Today
Wall Street analysts expect that Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Rating) will report $0.12 earnings per share for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Amneal Pharmaceuticals’ earnings. The highest EPS estimate is $0.13 and the lowest is $0.11. Amneal Pharmaceuticals reported earnings of $0.20 per share during […] ....
Wall Street brokerages predict that Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) will post sales of $500.68 million for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Amneal Pharmaceuticals’ earnings, with estimates ranging from $493.50 million to $508.70 million. Amneal Pharmaceuticals reported sales of $493.11 million during the same […] ....
Brokerages expect Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) to announce $0.12 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for Amneal Pharmaceuticals’ earnings, with estimates ranging from $0.11 to $0.13. Amneal Pharmaceuticals reported earnings of $0.20 per share in the same quarter last […] ....
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating)’s share price was up 6.1% during trading on Friday . The stock traded as high as $4.52 and last traded at $4.52. Approximately 36,090 shares changed hands during trading, a decline of 94% from the average daily volume of 635,615 shares. The stock had previously closed at $4.26. […] ....
Strs Ohio raised its holdings in shares of Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) by 20.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 191,800 shares of the company’s stock after buying an additional 32,300 shares during the quarter. […] ....